KRYS
Price:
$184.19
Market Cap:
$5.29B
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other presentations of aged or damaged skin; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syn...[Read more]
Industry
Biotechnology
IPO Date
2017-09-20
Stock Exchange
NASDAQ
Ticker
KRYS
According to Krystal Biotech, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.95B. This represents a change of 27.53% compared to the average of 3.88B of the last 4 quarters.
The mean historical Enterprise Value of Krystal Biotech, Inc. over the last ten years is 981.58M. The current 4.95B Enterprise Value has changed 50.37% with respect to the historical average. Over the past ten years (40 quarters), KRYS's Enterprise Value was at its highest in in the June 2024 quarter at 4.87B. The Enterprise Value was at its lowest in in the September 2017 quarter at -10864742.25.
Average
981.58M
Median
783.43M
Minimum
6.80M
Maximum
3.02B
Discovering the peaks and valleys of Krystal Biotech, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.80%
Maximum Annual Enterprise Value = 3.02B
Minimum Annual Increase = -85.02%
Minimum Annual Enterprise Value = 6.80M
Year | Enterprise Value | Change |
---|---|---|
2023 | 3.02B | 61.72% |
2022 | 1.87B | 53.06% |
2021 | 1.22B | 40.08% |
2020 | 870.51M | 25.01% |
2019 | 696.35M | 439.26% |
2018 | 129.13M | 1.80% |
2017 | 6.80M | -85.02% |
The current Enterprise Value of Krystal Biotech, Inc. (KRYS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
2.03B
5-year avg
1.53B
10-year avg
981.58M
Krystal Biotech, Inc.’s Enterprise Value is greater than MeiraGTx Holdings plc (287.90M), less than Apellis Pharmaceuticals, Inc. (5.11B), greater than Deciphera Pharmaceuticals, Inc. (2.15B), greater than REGENXBIO Inc. (668.33M), greater than Rhythm Pharmaceuticals, Inc. (3.10B),
Company | Enterprise Value | Market cap |
---|---|---|
287.90M | $300.31M | |
5.11B | $5.00B | |
2.15B | $2.21B | |
668.33M | $567.38M | |
3.10B | $3.01B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Krystal Biotech, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Krystal Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Krystal Biotech, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Krystal Biotech, Inc. (KRYS)?
What is the 3-year average Enterprise Value for Krystal Biotech, Inc. (KRYS)?
What is the 5-year average Enterprise Value for Krystal Biotech, Inc. (KRYS)?
How does the current Enterprise Value for Krystal Biotech, Inc. (KRYS) compare to its historical average?